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Abstract
Background
Of the 108 Schizophrenia (SZ) risk-loci discovered through genome-wide association stud-
ies (GWAS), 96 are not altering the sequence of any protein. Evidence linking non-coding
risk-SNPs and genes may be established using expression quantitative trait loci (eQTL).
However, other approaches such allelic expression quantitative trait loci (aeQTL) also may
be of use.
Methods
We applied both the eQTL and aeQTL analysis to a biobank of deeply sequenced RNA from
680 dorso-lateral pre-frontal cortex (DLPFC) samples. For each of 340 genes proximal to
the SZ risk-SNPs, we asked how much SNP-genotype affected total expression (eQTL), as
well as how much the expression ratio between the two alleles differed from 1:1 as a conse-
quence of the risk-SNP genotype (aeQTL).
Results
We analyzed overlap with comparable eQTL-findings: 16 of the 30 risk-SNPs known
to have gene-level eQTL also had gene-level aeQTL effects. 6 of 21 risk-SNPs with
known splice-eQTL had exon-aeQTL effects. 12 novel potential risk genes were identified
with the aeQTL approach, while 55 tested SNP-pairs were found as eQTL but not aeQTL.
Of the tested 108 loci we could find at least one gene to be associated with 21 of the risk-
SNPs using gene-level aeQTL, and with an additional 18 risk-SNPs using exon-level
aeQTL.
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Conclusion
Our results suggest that the aeQTL strategy complements the eQTL approach to suscepti-
bility gene identification.
Background
The large-scale efforts of genome-wide association studies (GWASs) have in recent years dis-
covered hundreds of single-nucleotide polymorphisms (SNPs) associated with common com-
plex disease. The high reproducibility and well-supported causal link to disease means that
these risk SNPs represent precious knowledge towards advances in drug development. How-
ever, so far, only few examples of actual implementation as drug candidates exist. We believe
that the main reason for this is the lack of a precise understanding of how risk SNPs affect
genes and, ultimately, druggable targets. Linking risk SNPs with risk genes is of major impor-
tance, and currently, this has been of only limited success.
One reason for this is that the vast majority of risk SNPs are non-coding and thus without
an immediately obvious culprit gene. Typically, only 10% of GWAS-identified risk SNPs affect
the protein sequence directly or through high-linkage disequilibrium (LD) proxies [1]. In the
search for gene identification, most risk SNPs have been analyzed using eQTL methods, which
often cases can link a non-transcribed SNP to the expression of a proximal gene [2] [3]. The
eQTL method has so far identified a functional association for 30–50% of risk SNPs in brain
[2, 4, 5]. In the case of the Schizophrenia (SZ) GWAS original report, 16% of the findings were
shown to have brain eQTL effects at the gene level [1], but further studies are increasing this
number [6, 7]. The current state of the art analysis of GWAS SNPs and all expression features
in the transcriptome suggests that over 50% of the GWAS SNPs are associated with transcrip-
tion [7]. Understanding the mechanisms and mediator-genes of these risk-SNPs are of pri-
mary importance for translation of the genetic findings. For this reason, we set out to compare
allelic expression quantitative trait loci (aeQTL) that serves the same purpose as an eQTL but
is based on the allele fraction within each individual, instead of the total expression from both
alleles. We use the term aeQTL to designate imbalances in expression due to stoichiometric
variation of a specific genomic variation. We combined a computational phasing of genotypes
with deep RNA-seq analysis to identify genes with strong imbalance as correlating with proxi-
mal heterozygous GWAS-identified risk-SNPs. For investigation of neighboring genes, the use
of haplotypes can give us reproducible phase estimates even when LD is low (Figure 1 in S1
File). The concept is illustrated in Fig 1: In aeQTL, only samples where the gene has heterozy-
gous transcribed SNPs (txSNPs) can have an allele fraction calculated. When heterozygous, the
txSNPs function as reporters of allelic transcription from the risk chromosome copy. In this
analysis we have used txSNPs within the exons of each gene investigated, and the allele fraction
was set relative to the parent 1 phase, based on phasing results. Therefore, if there is a link with
a risk-allele that increases gene expression, the allele fraction should attain one of three levels:
i) >0.5 if the txSNP and the risk SNP are in one phase; ii) Close to 0.5 if the risk-SNP is homo-
zygote, iii) <0.5 if the txSNP and the risk-SNP are in the opposite phase [8]. Thus, the allelic
imbalance is a more subtle autosomal version of the well-known X-chromosome inactivation
process [9].
We here present the results of comparing eQTLs and aeQTLs in a deeply sequenced bio-
bank of brain samples, with the goal of illustrating how allelic imbalance genetics may serve as
a possible complement.
aeQTL in schizophrenia
PLOS ONE | https://doi.org/10.1371/journal.pone.0217765 June 17, 2019 2 / 16
and Mental Health DAC (JAAMHDAC@mail.nih.
gov).
Funding: Lundbeck A/S provided support in the
form of salaries for authors LF, JN, NP, and MD,
but did not have any additional role in the study
design, data collection and analysis, decision to
publish, or preparation of the manuscript. The
specific roles of these authors are articulated in the
‘author contributions’ section.
Competing interests: A consortium comprising
The Lieber Institute for Brain Development, Pfizer,
Lilly, Roche, Astra Zeneca, Astellas and Lundbeck
paid for the material in the study. However, these
companies had no influence over the conclusions
of the study. The funding from Lundbeck A/S does
not alter our adherence to PLOS ONE policies on
sharing data and materials.
Abbreviations: aeQTL, Allele specific expression
quantitative trait loci; DLPFC, Dorso lateral
prefrontal cortex; eQTL, Expression quantitative
trait loci; GWAS, Genome wide association studies;
LD, Linkage disequilibrium; SNP, Single nucleotide
polymoprhism; SZ, Schizophrenia; txSNP,
transcribed SNP.
Methods
Subjects and biopsies
A total of 782 individuals were included in the study. The Post-mortem human brain tissue
was obtained by autopsy with informed consent from the legal next of kin (protocol 90-M-
0142 approved by the NIMH/NIH Institutional Review Board), in accordance with the decla-
ration of Helsinki. Brain samples were obtained from the dorsolateral pre-frontal cortex
(DLPFC) (n = 680). Additionally, from the same individuals, DNA was isolated from cerebel-
lar samples for the purpose of genome-wide genotyping and a set of hippocampal formation
tissue (n = 421) was used for replication. The age of the individuals ranged from birth to 97
years of age, although a complementary analysis including pre-natal samples are found in
Tables S5 and S6 in S1 File. The ethnicity was primarily Afro-American and Caucasian. The
mean post-mortem interval was 33.4±20.1 minutes and the mean RIN-value was 8.1±0.9. Fur-
ther details are described elsewhere [7].
Genotyping and RNA sequencing
For genotyping, the Illumina Human1M-Duo v3.0, illumina 650K and omniX+ microarrays
were used. Data was merged using Plink (1.90beta3). The Shapeit2 software (v2.r790) [10] was
used for pre-phasing, and impute2 (version 2.3.2) for imputation and phasing, using the
1000genomes phase III reference panel.
Fig 1. Comparison of eQTL and aeQTL for PRMT7 and the rs8044995 risk-SNP. (A) In a standard eQTL analysis the X-axis (input variable) is the
genotype of the risk-SNP and the Y-axis (response variable) is the expression of the gene. (B) aeQTL analysis of the same risk-snp/gene pair. The Y-axis
shows the fraction of reads coming from the Parent 1 chromosome in the PRMT7 gene. Only samples with a heterozygous txSNP are included, and in
samples with more than one heterozygous txSNP the average fraction is used. The X-axis shows the risk-SNP group: samples that are heterozygote with
an A-allele on the Parent 1 chromosome are in group 1, samples that are homozygote (A/A or G/G) are in group 2, and samples with a G-allele on the
Parent 1 chromosome are in group 3. The linear regression of these values constitutes the basis of the aeQTL model. The supplementary S2 File
provides plots for all gene-SNP pairs that are listed in Table 1.
https://doi.org/10.1371/journal.pone.0217765.g001
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For the RNA-sequencing of DLPFC and Hippocampus, the library was prepared either by
depletion of rRNAs by RiboZero or by a polyA+ extraction of all fragments containing a poly-
A tail. Two samples per lane were used producing an average of 129.8 million paired-end
reads per sample (Figure 2 and Table S1 in S1 File. Further data access is available at the Lieber
Institute’s online data browser (http://eqtl.brainseq.org).
Data pre-processing
STAR software (2.4.2a) was used to align the RNA-sequencing data to the human genome
(assembly GRCh37). This was done both in a non-masked and masked version, where the
masked reference genome additionally used the ambiguity nucleotide character N for all SNPs
in the UCSC track snps142Common, (assembly GRCh37/hg19). Additional re-alignments
with masking of RNA-seq-called SNPs were performed. Samtools mpileup (version 0.1.19)
was used to discover the variant-positions in the RNA-seq data (samtools mpileup—BCF—
skip-indels—positions), and bcftools was used to loosely pre-filter these (bcftools filter—exclude
‘MIN(QUAL)<10 | MIN(DP)<10 | AC<10’). To reduce multiple testing burden the analysis
was restricted to include genes only within 200kb from the 108 SZ risk loci, this was motivated
by the complex phasing reproducibility pattern shown in Figure 1 in S1 File. The AllelicImba-
lance package was then used to import relevant read counts at each of the discovered txSNPs
[11]. The mapped reads were summarized as read counts for each allele type at each txSNP,
and their phase information inferred from shapeit2 was added, which made it possible to cal-
culate the phase specific fraction for parent 1. These AllelicImbalance data-objects were consid-
ered as the pre-processed basis of all further aeQTL analysis.
Filtering, defining of regions and pairing of risk-SNPs
On the pre-processed AllelicImbalance objects we further set a threshold of at least 10 reads
from each allele for a txSNP and restricted the analysis to exons including the 5’ and 3’ UTR.
We also required that at least 10% of the total expression came from the less expressed allele, to
hinder sequencing errors creating false allelic imbalance. All genes or txSNPs having at least 5
usable individuals in at least two genotype groups were used in the regression model. The
amount of remaining usable individuals for the analysis can be seen in Fig 2A and 2B.
Further, txSNP-regions were defined according to the UCSC RefSeq gene annotation data-
base (version 12-11-2015) in a way that each txSNP-region corresponded to one gene. The
only exception was overlapping genes, which were included in the same txSNP-region. Using
the phase information, we then summarized all txSNPs in the region to get a single value for
each sample.
Analyzing aeQTL through the use of phasing information
Our method for assessing aeQTLs was inspired by previous work by Almlo¨f et al, in which
expression microarrays were used to obtain allele-specific expression information, and then
combined with computationally phased genotypes to link the allele-specific expression with
non-transcribed SNPs [8]. LD information is correlated, but not outperforming phasing using
the 1000Genomes reference panel as illustrated in Figure 1 in S1 File. Two main parts were of
importance: Firstly, as with all allelic imbalance based methods, this required the presence of a
heterozygous SNP to discern between alleles. To maximize the number of testable genes, sum-
marization of data from all txSNPs in a gene (txSNP-region) was therefore used. Secondly,
since all genotypes were computationally phased, the relevant allelic imbalance fractions were
always calculated in the parent-1-allele direction. Taken together this prompts the fractionP1
variable, which is defined as the number of parent-1 reads divided by reads from both
aeQTL in schizophrenia
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chromosome copies, over all txSNPs in a gene (txSNP-region). Since the non-transcribed risk-
SNP is also phased, the association between risk-SNP and the allelic imbalance it creates can
be investigated using the linear regression model:
fractionp1 � risk   SNP   groupþ covariates
Fig 2. Filtration and mapping bias considerations in analysis pipeline. (A) Shows the least amount of individuals (Y-axis) for a given amount of
txSNPs (X-axis) at different condition levels, namely Het, i.e. count of heterozygous SNPs, Het+filt, i.e. the count of heterozygous SNPs that pass QC
filtration, and Hom, i.e. the remaining SNPs, which are homozygous. (B) Similar, but instead with an X-axis showing gene-count for which at least one
txSNP fulfills the condition level. In other words, the number analyzable individuals for a given amount of the genes of interest. (C) The fraction of
reference-allele containing reads measured over all txSNPs, dependent on using a masked or a non-masked genome. The horizontal line at 0.5 indicates
the expected fraction under the assumption of no mapping bias. Yellow indicates DLPFC tissue, green indicates Hippocampus tissue. (D) Number of
txSNPs in the genes of interest with at least one heterozygote sample among the 782 analyzed individuals.
https://doi.org/10.1371/journal.pone.0217765.g002
aeQTL in schizophrenia
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The risk-SNP-group value is enumerated as 0, 1 or 2; being either heterozygote of one
phase, e.g. A|G, homozygote, e.g. A|A and G|G, or heterozygote in opposing phase, e.g. G|A
(as illustrated in Fig 1A, and further detailed in Figure 1 in S1 File). Except when explicitly
noted otherwise, we always included the covariates age and sex as well as the first three princi-
pal components of the genotyping data and the first ten principal components of the RNA-seq
data. To correct for multiple testing we used a FDR 5% threshold, calculated over each risk-
SNPs—gene pair (n = 371). For the splicing analysis, we used a separate threshold calculated
over each risk-SNPs–txSNPs pair (n = 4032).
Comparable eQTL analysis
The eQTL P-values used for comparison are the Lieber- BrainSeq consortium P-values obtain-
able from this website: http://eqtl.brainseq.org/. They are calculated from the same set of
human brains, using the same covariates as for the aeQTL analysis, i.e. age, sex, three first
genotype principal components and first ten expression principal components. Additionally,
we linked comparable measurements from the Lieber BrainSeq consortium’s significant eQTL
splice evidence for any corresponding aeQTL gene-level evidence.
Results
Pre-processing motivates masked alignment in aeQTL analysis
RNA sequence data from brain tissue for all genes proximal to the known SZ risk-SNPs were
scanned for presence of heterozygous transcribed SNPs (txSNPs). In the 493 proximal genes,
defined as all genes within 200 kb of the 108 risk loci, a total of 3734 heterozygous txSNPs
were found in at least one of the analyzed individuals, illustrated in Fig 2D. With phasing,
these heterozygous txSNPs could function as reporters of transcription from the risk chro-
mosome copy. One set of filters were applied across all txSNPs: this included minimum
read-quality, and minimum read-count. Another was applied on basis of each sample: filtra-
tion on the minimum expression level and on minimum percent of fraction for each allele.
Altogether this left 340 of the 493 proximal genes amendable to analysis using the aeQTL
approach (Fig 2A and 2B). Because of proximity of some risk-SNPs, the 128 risk-SNPs and
the 340 genes, created 371 testable pairs of a total of 576 possible SNP-gene pairs in the
region.
A potential problem in aeQTL analysis is the propensity for reference genome (ref-allele)
allele containing reads to be favored over the alternative allele (alt-allele) during the alignment
procedure, thereby introducing what is known as a mapping bias. Realignment of all raw reads
was therefore performed using a reference genome that was masked at each of the 3734
txSNPs, referred to as the masked alignment. An aeQTL analysis was performed using both
alignments, discovering 42 and 34 aeQTLs in the unmasked and masked alignments respec-
tively (Figure 3 in S1 File). However, calculation of overall reference allele fraction in both the
masked and unmasked data set showed that the reference allele was particularly favored when
using an un-masked reference genome (Mean 0.515±0.14). Using a masked reference genome
during the alignment shrinks the effect (Mean 0.505±0.14), Fig 2C, Table S2 in S1 File, which
is consistent with results by others [12]. This finding justified the exclusive use of the masked
alignment for all subsequent analyses. An additional investigation of mapping bias for the sig-
nificant aeQTLs showed no significant effect on the result. Generated QQ-plots and plots for
inspection of heteroscedasticity at the level of each significant aeQTL confirmed the usability
of a linear regression model, Figs 1 to 52 in S2 File.
aeQTL in schizophrenia
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Analysis of QTLs in brain tissue reveals novel causal risk genes for
schizophrenia
Of the 340 proximal genes analyzed, we found evidence of risk-SNP mediated gene expression
modulation for 30 genes, located proximal to 21 SZ risk-SNPs. This difference was a conse-
quence of 9 risk-SNPs having aeQTL effects with more than one gene (see Fig 3), a concept
which is in line with previous eQTL findings [13]. We found that 4 SNPs and 12 gene-SNP
pairs did not previously have evidence of missense proxies or brain eQTL (bold text, Table 1).
Fig 4 shows an overview of previously found gene-level brain eQTLs [1, 6, 7] and coding evi-
dence [1] proximal to the 108 SZ risk loci.
All pairs of risk-SNPs and genes at 200 kb range were investigated and are included in the
table if they have a FDR5% significant aeQTL effect (P< 0.0025). The risk-SNPs are
highlighted in bold when no other functional evidence exists for that loci, i.e. no coding proxy
(1), no gene-level brain eQTL (1,6,7) and no splice-level brain eQTL (7). Similarly, the gene-
symbol is highlighted in bold when no other functional evidence exists for that gene-SNP pair
(same criteria). Pos: position. Dist: distance in kb. Dist rank: rank of gene by proximity to risk-
SNP. Ref/Alt: reference and alternative allele. Bold indicates the SZ-risk increasing allele. Dir:
gene expression direction induced by risk allele, indicated both for eQTL and aeQTL, when
significant. txSNP: count of transcribed SNPs in gene with at least one heterozygote sample.
Reads: The mean read coverage of the individuals for the txSNPs with highest coverage. N
group: count of samples with at least one heterozygous txSNP stratified by risk-SNP groups (as
defined in Fig 1A). Further gene-SNP evidence: Js = Jaffe-splice-QTL, Fg = Fromer-gene-
eQTL (CommondMind), Rc = Ripke-Coding, Rg = Ripke-gene-eQTL. Tissue: DLPFC, dorso-
lateral pre-frontal cortex. HIPPO: comparative analysis in hippocampus data.
The main goal of this analysis was to introduce the novel concept of aeQTL risk-SNP analy-
sis and show how it adds to the eQTL method by increasing new QTL discoveries. Of the 34
significant aeQTLs in this analysis, 30 unique SNP-gene pairs were discovered by aeQTL at
Fig 3. Plot of aeQTL effects in the genes surrounding the rs2905426 risk-SNP. Each box in the annotationTrack shows one gene. Each dot shows one
analyzable txSNP. The X-position of the dot indicates location in gene, and the Y-position indicates the aeQTL significance levels as–log10(P). The
horizontal line indicates txSNP level significance at FDR5% (P = 0.0030). The color of each dot indicates effect-direction, red corresponds to increased
fraction of ref-allele containing reads. The intensity of the color corresponds to the number of samples analyzable for the given txSNP, with 100 or more
samples shown as fully saturated color. The GeneRegionTrack indicates the location of all the genes of interest surround this risk-SNP. The risk-SNP is
indicated as a vertical red line. The top track contains the name of the gene as well as the P-value of the strongest associated txSNP.
https://doi.org/10.1371/journal.pone.0217765.g003
aeQTL in schizophrenia
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FDR5%, 10 SNP-gene pairs had FDR5%-significant direction-consistent evidence from both
eQTL and aeQTL, and 6 additional FDR5%-significant aeQTL associations had nominal
eQTL significance (P<0.05) in the same direction. These counts are further detailed in Table 1
in the column “direction aeQTL/eQTL”, wherein pairwise significance and direction are indi-
cated for every SNP-gene pair that had FDR5% significant aeQTL effects. Obversely, 55 tested
SNP-gene pairs were found as eQTL but not aeQTL.
In the two investigated brain regions, we found that the majority of expression association
evidence was found in DLPFC, and not confirmed in hippocampus. Of the 30 SNP-gene pairs
Fig 4. Overview comparing gene-level eQTL and aeQTL findings for the SZ risk-SNPs under analysis. Each bar corresponds to a single risk-SNP
and the height of the bar shows the number of genes within 200kb. The color code indicates which of these genes have mechanistic evidence, either
from previous or current work. Mechanistic evidence is here defined as either missense SNPs in proxy with the GWAS risk SNPs, gene-level eQTL
effects, or aeQTL effects. Note that all 124 risk-SNPs in the 108 loci are shown, including 13 risk-SNPs with no genes within 200kb.
https://doi.org/10.1371/journal.pone.0217765.g004
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observed by aeQTL, 4 were replicated in the smaller set of hippocampus data. Since the
DLPFC data set was slightly larger than the hippocampus (n = 680 vs n = 421), we repeated
this analysis with a downsampling of the DLPFC, still obtaining overrepresentation of DLPFC
findings (Figure 4 in S1 File). There were not enough fetal samples to conduct a separate analy-
sis to highlight developmental genes, but including the additional 58 fetal samples in the
cohort to the main analysis can suggest genes more sensitive to developmental changes. We
found 11 other associations, 8 in DLPFC and 3 in hippocampus, all borderline significant
except CENPM (p = 2.4e-12) and EFTUD1P1 (p = 2.8e-05) for eQTL, and the “GNL3,
SNORD19, SNORD69, SNORD19B” region (7e-04) for aeQTL. The inclusion of the 58 fetal
samples also resulted in a loss of 7 borderline significant associations, 5 in DLPFC and 2 in hip-
pocampus (Tables S5 and S6 in S1 File). Overall, these findings indicate that novel gene associ-
ations can be established with aeQTL, that there is overlap between this method and the eQTL
method, and that DLPFC tissue contains more transcriptomic associations of SZ risk-SNPs
than hippocampal tissue.
Detailed investigation of each txSNP reveals possible splice effects
Although each gene only has a limited amount of analyzable txSNPs, we explored if the
aeQTL-differences in the txSNP of each gene could nonetheless be used to describe possible
splice effects. We expect neighboring txSNPs within the same gene should show similar effect-
size and direction, if they are not affected by splice effects. Conversely, splice-effects may be
observable as differences in effect-size and direction. We therefore investigated each txSNP in
the genes of interest, illustrated by Fig 3 that shows the example of HAPLN4 (all others are
available as Figures 1 to 65 in S3 File). While the HAPLN4 region showed an example of con-
sistent unidirectional aeQTL effects from all txSNP in a single gene, this was not always the
case: the txSNP-level plotting revealed a number of cases with non-significant gene-level met-
rics, but strong independent aeQTL-effects from some txSNPs. Taking the increased multiple-
testing burden into account we found 156 txSNPs with aeQTL effect significant at FDR5%
level (Tables S3 and S4 in S1 File), associating 18 more risk-SNPs not found by aeQTL at the
gene level. The txSNP aeQTL approach could conceivably be used for a similar purpose as
splice eQTL investigations described elsewhere [7].
Interaction analysis provides possible explanations of discrepancy between
eQTL and aeQTL
To study the discrepancies between eQTL and aeQTL and attempt to discover their causes we
re-calculated all QTLs using covariates likely to have influence. These included RNA-integrity
number (RIN), age, sex, diagnosis and smoking status. Particularly for RIN-value we wished to
test the hypothesis that aeQTL was less affected by changes in RNA quality. While attractive as
an example case, the systematic analysis did not completely support that RIN value is a main
covariate for all risk-SNP gene pairs; using a binary cutoff at RIN 8, eQTL analysis showed 5
pairs with interaction effects, in aeQTL analysis only 1 pair did (Figure 5 in S1 File). Some
examples of this were found, including the gene LRRN3 and risk-SNP rs13240464 which
showed significant interactions with RIN-values(Pinteraction = 1.36e-04), raising an uncertainty
regarding the main effect of the eQTL at lower RNA qualities, as the low RIN samples show a
significant eQTL (P = 0.00049) (Figure 6A in S1 File): The aeQTL analysis for the same risk-
SNP gene pair showed no significance interaction (Pinteraction = 0.37), and showed no signifi-
cant aeQTL for low RIN-value (P = 0.51) (Figure 6B in S1 File). In Figure 7 in S1 File, eQTL
appears more sensitive to RIN covariates than aeQTL, and we can also see that addition of
aeQTL in schizophrenia
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more covariates has a higher effect on eQTL. In particular, including genetic and expression
PCs changes the p-value more than for RIN, which suggests that for brain tissue more covari-
ates than the RIN value is likely to be important. The use of aeQTL can be used to partially cir-
cumvent these covariates, and be a good compliment to standard eQTL analysis. Likewise, the
remaining covariate analyses gave some possible explanatory examples, but were not able dis-
cover a fundamental explanation for discrepancies.
Discussion
The eQTL approach is an established tool to link non-transcribed GWAS risk-SNPs with tran-
scribed proximal genes. In this paper, we explore and compare with the possibly complimen-
tary aeQTL approach. This method is inspired by previous microarray-based studies, in which
phasing of genotypes is used to link txSNPs with a non-transcribed (risk) SNP [8]. We here
refer to this linking as aeQTL analysis, and describe a study were the method is adapted to
RNA-sequencing data, enabling the systematic uncovering of previously concealed expres-
sion-modulating effects from all known SZ GWAS-risk SNPs. The overall goal is to compare
established (eQTL) and alternative tools (aeQTL) for functional linking of GWAS risk-SNPs
and genes.
Findings
In the previous brain eQTL analysis it was shown that 30 loci have gene-level eQTL and an
additional 21 loci had splice- or exon-eQTL [7]. In this study, 16 and 6 of those loci were also
identified using the gene-level and exon-level aeQTL approach, respectively, but not necessar-
ily pointing towards the same gene. We speculate that these discrepancies may arise from the
complexity of transcriptional regulation, such as for example how feedback loops may work to
mask one method but not the other. While the goal of both eQTL and aeQTL is the same–to
functionally investigate links between SNPs and genes–the approach is different. Clearly, the
eQTL approach has potentially greater resolution because it does not require an expressed het-
erozygous SNP, as the comparison data show, but the aeQTL strategy may uncover additional
genetic associations missed in the eQTL analysis. Overall, we found that 30 genes proximal to
21 known SZ risk-SNPs showed evidence of risk-SNP mediated allelic expression modulation
(aeQTL).
Several of the findings emphasize already known links to brain functioning and develop-
ment. In addition to eQTL-discoverable genes such as CHRNA5, MAPK3 and AS3MT [14–
16], these include the HAPLN4 (Brain Link Protein 2), and the RIMS1 (Regulating Synaptic
Membrane Exocytosis 1). Several additional findings in Table 1 are of interest to follow-up
with further studies: one signaling receptor, peptidase, translocase, transferase and two chaper-
onins together with several kinases and phosphatases. Systematic gene set enrichment analysis
has already been performed in the initial GWAS as well as follow-up studies [1]; however, the
main point to underscore is that such analysis often make the mistaken assumption that the
closest gene is the mechanistically relevant gene. As shown in the dist-rank column of Table 1,
and also evidenced by similar findings elsewhere [17], the closest gene is often not the func-
tionally relevant gene. This was the case for 39 of 58 reported SNP-gene pairs in this analysis,
which illustrates the strength of strengthening the use of functional genetics methods, such as
eQTL and aeQTL, in order to arrive at more solid knowledge of risk-genes rather than just
risk-SNPs and the genes next to them. Future studies might be further improved by combining
this approach with colocalization analysis.
aeQTL in schizophrenia
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Challenges of using the aeQTL method
The first challenge is that at least some samples need to be heterozygous for one or more
txSNPs to produce a reliable regression model. A second problem is that some deviation from
1:1 may be ascribed to a mapping bias. Thirdly, to link the risk SNP with an AI event in the
most effective manner, it is necessary to know the phase of the alleles, a challenge for which
several solutions exists. In this paper, we present and apply calculation pipelines that address
these three issues, and discuss what limitations remain for each.
To measure allelic imbalance, it is a requirement that a gene have one or more txSNPs that
are heterozygous. This problem diminishes with larger sample sizes, as well as longer and less
conserved genes. This problem was overcome in part by the creation of a system that summa-
rized consecutive txSNPs within a gene evaluating their joint AI. This enabled us to investigate
a total of 340 genes, thereby largely addressing the problem of lack of heterozygous txSNPs
(Fig 2D).
The problem of mapping bias appears when RNA-seq reads containing the reference allele
have larger likelihood of successful mapping, than those containing the alternative allele. By
looking at the overall mean of all SNPs we observed that the average ref-allele fraction of all
SNPs was different from the expected value of 0.5, indicating a modest but non-ignorable bias.
To address this, we re-aligned the RNA-sequencing data using a version of the reference
genome that was N-masked at all common SNP locations; this altered the ref-allele frequency
to mean 0.505±0.14, reinforcing the notation that mapping bias is a potential issue in AI-calcu-
lations (see Fig 2C). Even if mapping bias is detrimental when looking at the allele frequency
for only one individual, the problem is reduced if the bias is spread equally over all genotype
groups i.e., the ref-allele is equally present over all genotype groups. Even though the summari-
zation step is advantageous to increase the pool of heterozygote samples, there is a risk when
using fraction mean that some reads overlap multiple txSNPs. Other approaches to this have
been developed, include handling of the potential for very proximal txSNPs [18].
This situation is nevertheless not unique to aeQTL, as there exist a similar concern in eQTL
studies, where RNA sequencing mapping bias or microarray allele specific hybridization may
have an impact on the result. To test for any impact by mapping bias on our aeQTL after mask-
ing we performed a linear regression using the ref-allele fraction for each genotype group.
Even if we could see remains of mapping bias for certain genes, none showed any significant
relationship to the genotype group, supporting that our aeQTLs found were real and not due
to technical artifacts (Supplementary Figures 1 to 52 in S2 File).
Finally, to link allelic imbalance with a (non-transcribed) risk SNP, phase has to be known
in order to match the alleles of the txSNPs with the alleles of the risk SNP. The allele fraction
calculated could suffer from uncertainty in phase generation, but this will be randomly distrib-
uted, introducing noise but not biasing the results. Other methods have been explored for
doing this, by assuming that the AI for the heterozygous risk-SNPs should have a higher vari-
ance than the homozygote risk-SNPs [19], but we found the statistical power of such analysis
is drastically reduced, and we could not find any associations in our data (Figures 1 to 52 in S2
File). From this we conclude that phasing-based methods are the stronger for linking txSNPs
and non-transcribed SNPs.
Functionality for using these approaches has been implemented into the AllelicImbalance
package, which is available in the Bioconductor repository [11].
Contrary to our initial hypothesis regarding the quality of samples from brain tissue and its
confounding effects on eQTL, our results indicate a relatively little impact of RIN. This is in
the same line as previous research where genotype did not significantly associate with RIN
[20]. Recent work has demonstrated that RIN is not an adequate approach to RNA quality
aeQTL in schizophrenia
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correction and that other methods may be indicated to further resolve this issue [20]. The
increase of QTLs by using allelic imbalance information is more likely coming from its ability
to remove the variation caused by trans-regulation of transcription.
Conclusion
We have compared eQTL and aeQTL strategies in the context of human brain and schizophre-
nia risk SNPs. The main conceptual points we pursued in this study are i) the description of
methodology for linking allelic imbalance with non-transcribed risk-SNPs in RNA-sequencing
analysis and the ii) application of this methodology to a brain-tissue biobank. Overall, we find
that the two methodologies have an overlap of significant QTLs, but also some differences
where each method can find additional QTLs. We have discussed possible explanations for the
differences, such as heterozygozity, read-depth, phasing, sample size and trans-regulation.
However, further research will be required for determining the exact mechanism behind the
differences. Taken together we believe these findings will have implications for how we use
functional genetics to link GWAS risk-SNPs with genes.
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